J&J admits suture recall after UK agency posts info

Johnson & Johnson, ($JNJ) which has been plagued by repeated recalls of consumer medicines and medical devices over the past year, said it pulled 107 batches of surgical sutures in December because of potential sterility problems. The recall only came to light this week after UK regulators described it on an agency website. Report

Suggested Articles

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.

A patent decision in Delaware clears the way for multiple generic companies to launch their Tecfidera copycats—and target its $3.3B in U.S. sales.

Sanofi and GlaxoSmithKline signed a deal with the EU to supply up to 300 million doses of their recombinant protein-based COVID-19 vaccine.